Petter Veiby
Vermogen: 2 M $ op 31-08-2026
Vermogen: 2 M $ op 31-08-2026
Mr. Petter Veiby is a Chief Scientific Officer at Attovia Therapeutics, Inc. He is on the Board of Directors at BiVictriX Therapeutics Plc.
Mr. Veiby was previously employed as a Senior Director by Takeda Oncology Co., a Senior Vice President-Business Development by Immunitas Therapeutics, Inc., a Head-Alliances by Zai Lab Ltd., and a Global Head-Biotherapeutics by Takeda Oncology Co.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 05-08-2026 | 104.952 ( 0,23% ) | 2 M $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ATTOVIA THERAPEUTICS, INC. | Oprichter | 16-12-2022 |
| BIVICTRIX THERAPEUTICS PLC | Directeur/Bestuurslid | 01-08-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Directeur/Bestuurslid | 01-06-2023 |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Corporate Officer/Principal | 01-11-2022 |
| ZAI LAB LIMITED | Corporate Officer/Principal | 01-05-2022 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01-03-2020 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Zai Lab Ltd.
Zai Lab Ltd. BiotechnologyHealth Technology Develops medicine for cancer, autoimmune and infectious diseases | Health Technology |
BiVictriX Therapeutics Plc
BiVictriX Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and distributes cancer therapeutics | Health Technology |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Health Technology |
Attovia Therapeutics
Attovia Therapeutics BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that researches & develops therapeutic products in the fields of immune-mediated diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau